Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-09

Clinical Trial Update: Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy volunteers evaluating Linaclotide Acetate for preventing colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linaclotide Acetate (linaclotide acetate)

Snippet

Sponsor: Mayo Clinic | Conditions: Colorectal Cancer, Healthy, no Evidence of Disease | Phase 1 | Status: COMPLETED